Sun Wave Pharma S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across various regions. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic medications and innovative healthcare solutions. With a diverse portfolio that includes therapeutic areas such as cardiology, oncology, and neurology, Sun Wave Pharma is committed to enhancing patient care through its unique formulations and rigorous quality standards. The company has achieved significant milestones, including strategic partnerships and a growing presence in international markets, solidifying its position as a trusted name in pharmaceuticals. Recognised for its dedication to research and development, Sun Wave Pharma continues to push the boundaries of medical science, ensuring that it meets the evolving needs of healthcare professionals and patients alike.
How does Sun Wave Pharma S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sun Wave Pharma S.R.L.'s score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sun Wave Pharma S.R.L., headquartered in Romania (RO), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Ascendis Health Limited, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Sun Wave Pharma S.R.L., it is important to note that the company is part of a broader corporate family that may have its own sustainability initiatives. The emissions data and climate strategies from Ascendis Health Limited could potentially inform Sun Wave Pharma's environmental impact and commitments. As a subsidiary, Sun Wave Pharma S.R.L. may benefit from the sustainability frameworks and targets set by Ascendis Health Limited, although specific details on these initiatives are not provided. The absence of direct emissions data suggests that the company may still be in the process of establishing its own climate strategy or reporting mechanisms. In summary, while Sun Wave Pharma S.R.L. does not currently disclose emissions data or specific climate commitments, its affiliation with Ascendis Health Limited may play a role in shaping its environmental policies in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sun Wave Pharma S.R.L. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.